Laura Prendergast
Stock Analyst at Raymond James
(0.57)
# 3,862
Out of 4,761 analysts
8
Total ratings
42.86%
Success rate
-26.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| THRD Third Harmonic Bio | Downgrades: Market Perform | n/a | $3.58 | - | 2 | Feb 11, 2025 | |
| MURA Mural Oncology | Initiates: Strong Buy | $18 | $4.22 | +326.54% | 1 | Oct 4, 2024 | |
| NKTX Nkarta | Upgrades: Strong Buy | $16 | $2.15 | +644.19% | 2 | Aug 14, 2024 | |
| BDTX Black Diamond Therapeutics | Initiates: Outperform | $20 | $2.28 | +777.19% | 1 | Jul 31, 2024 | |
| RVMD Revolution Medicines | Upgrades: Strong Buy | $36 → $48 | $42.26 | +13.58% | 2 | Apr 10, 2024 |
Third Harmonic Bio
Feb 11, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $3.58
Upside: -
Mural Oncology
Oct 4, 2024
Initiates: Strong Buy
Price Target: $18
Current: $4.22
Upside: +326.54%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.15
Upside: +644.19%
Black Diamond Therapeutics
Jul 31, 2024
Initiates: Outperform
Price Target: $20
Current: $2.28
Upside: +777.19%
Revolution Medicines
Apr 10, 2024
Upgrades: Strong Buy
Price Target: $36 → $48
Current: $42.26
Upside: +13.58%